Area De Salud De Burgos Y Soria

At Area De Salud De Burgos Y Soria, the Oncology department is running a broad portfolio of trials focused on neoplasms and related blood cancers. Research here includes studies aimed at improving treatment outcomes for breast cancer, lung cancer, colorectal cancer, gastric cancer, and several forms of lymphoma and leukemia.

• Trials evaluating new treatment strategies for early and advanced breast cancer, including hormone receptor-positive and HER2-related disease
• Studies in hematologic malignancies such as multiple myeloma, acute myeloid leukemia, chronic lymphocytic leukemia, and lymphoma
• Research in solid tumors, including non-small cell lung cancer, hepatocellular carcinoma, head and neck cancer, and gastrointestinal cancers

Much of the work at this hospital/clinic site is designed to test new therapies, compare them with current standards, and improve long-term disease control, survival, and relapse prevention in patients with cancer.

A major research focus at the site covers hemic and lymphatic diseases as well as selected immune system diseases. These trials study conditions such as immune thrombocytopenia, warm autoimmune hemolytic anemia, and other autoimmune cytopenias, with the goal of finding better ways to restore blood counts and reduce bleeding or anemia.

• Studies testing therapies for immune thrombocytopenia and primary immune thrombocytopenia
• Research on autoimmune hemolytic anemia and broader autoimmune cytopenias
• Trials in lymphoma and myeloma that aim to improve response rates and disease control

This area of research is centered on evaluating treatment effectiveness and safety in disorders where the immune system affects the blood, while also exploring options that may reduce the need for rescue treatment.

The site also participates in studies within nervous system diseases and psychiatry and psychology. Key conditions include Huntington’s disease, Parkinson’s disease, schizophrenia, autism spectrum disorders, and Tourette syndrome, reflecting a strong interest in both movement and behavioral disorders.

• Trials seeking to slow progression or improve symptoms in Huntington’s disease and Parkinson’s disease
• Studies focused on schizophrenia and cognitive or negative symptoms
• Research in autism spectrum disorders and Tourette syndrome aimed at improving communication, behavior, and quality of life

These investigations are mainly intended to assess symptom control, functional improvement, and the long-term safety of emerging or repurposed treatments.

Clinical research at this site extends into respiratory tract diseases, bacterial infections and mycoses, and virus diseases. Trials include studies in chronic obstructive pulmonary disease, eosinophilic asthma, allergic rhinoconjunctivitis, respiratory syncytial virus infections, and serious bacterial or fungal infections.

• Studies evaluating better control of COPD and asthma
• Research on allergic rhinitis and allergic rhinoconjunctivitis to improve seasonal symptom relief
• Trials in infectious diseases such as P. aeruginosa bacteremia, fungal infections, and RSV

The purpose of this research is to improve diagnosis and treatment effectiveness, while also reducing complications and treatment burden in patients with chronic or acute respiratory and infectious conditions.

Another important research area includes cardiovascular diseases, digestive system diseases, and pathological conditions seen in acute care. Trials cover acute pulmonary embolism, acute myocarditis, heart failure, chronic kidney disease, end-stage kidney disease, and preeclampsia.

• Studies aimed at improving management of pulmonary embolism, myocarditis, and heart failure
• Research on kidney disease and dialysis-related care
• Trials in acute and supportive care, including postoperative pain and metabolic complications

These trials generally focus on testing whether existing or new approaches can improve clinical outcomes, reduce complications, and support safer care for patients with complex medical needs.

Beyond its main oncology focus, the site contributes to studies in ophthalmology, urology, gastroenterology, and pharmacogenetics. Research topics include wet age-related macular degeneration, prostate cancer, ulcerative colitis, recurrent pancreatitis, and the use of genetic information to personalize treatment.

• Trials exploring eye disease treatments to preserve vision in neovascular AMD
• Studies in prostate cancer and digestive disorders such as ulcerative colitis
• Research on pharmacogenetics to improve medication choice and reduce adverse reactions

This diverse portfolio shows a strong interest in treatment optimization across both common and specialized conditions, with an emphasis on practical benefits for patients and clinicians.